Adherence management in transplantation

2021 ◽  
pp. 409-448
Author(s):  
Sabina M. De Geest ◽  
Janette Ribaut ◽  
Kris Denhaerynck ◽  
Fabienne Dobbels
Keyword(s):  
Adherence Management

Excellence in adherence management

2005 ◽  
Vol 16 (6) ◽  
pp. 55-57
Author(s):  
Sherry Aliotta ◽  
Susan Rogers
Keyword(s):  
Adherence Management

Student Pharmacists’ Perceptions of Barriers to Medication Adherence Counseling

2012 ◽  
Vol 26 (4) ◽  
pp. 376-381 ◽  
Author(s):  
Michelle N. Mangan ◽  
Mary F. Powers ◽  
Aaron J. Lengel
Keyword(s):  
Medication Adherence ◽  
Counseling Session ◽  
Specific Training ◽  
Online Surveys ◽  
Phone Calls ◽  
Adherence Counseling ◽  
The Subject ◽  
Pharmacy Chain ◽  
Adherence Management

Purpose: To identify the barriers perceived by student pharmacists to counseling on medication adherence in a supermarket community pharmacy chain. Methods: Online surveys were made available to 65 student pharmacists. Subjects completed the survey anonymously and indicated their opinions and perceptions on topics related to medication adherence through the use of a 5-point Likert-type scale. Results: Of the surveyed student pharmacists, 26 completed the survey (40%). All participants (100%) agreed that they have knowledge on the importance of medication adherence. Student pharmacists stated that they did not have the time to cover adherence in a counseling session (72.7%) nor did they have time to perform follow-up phone calls with the patient (54.5%). The majority of student pharmacists (81.8%) were comfortable bringing up the topic of adherence with the patient but thought that they did not have access to resources on adherence to provide to the patient (59%). Conclusions: Surveyed students indicated they were constrained for time to counsel patients on adherence and to perform continued follow-up with patients afterward. Factors cited as barriers to counseling patients on medication adherence include time, lack of specific training in adherence management, lack of resources to provide to the patient, and patient disinterest in the subject.

The Application of Intelligent Keywords to Patient Adherence Management System

2013 ◽  
Vol 4 (4) ◽  
pp. 102-119 ◽  
Author(s):  
Yin-Pin Yang ◽  
Tsai-Ya Lai
Keyword(s):  
Health Behavior ◽  
Behavior Change ◽  
Treatment Planning ◽  
Management System ◽  
User Behavior ◽  
Patient Adherence ◽  
Health Behavior Change ◽  
Healthcare Intervention ◽  
Intervention Adherence ◽  
Adherence Management

Health behavior change is the key challenge for healthcare intervention adherence management. For each treatment planning, patient adherence can be managed, audited, and improved by the Patient Adherence Management System applying Intelligent Keyword (PAMSIK) featuring the use of intelligent keywords, which has been design to navigate users to the target in-time knowledge and also leverage the collective power – peer learning to encourage patients. Three major components of PAMSIK are: an autonomous, intelligent, friendly User Behavior Collector to identify patient's personal adherence problems, a Patient Similarity Analyzer to dynamically cluster peers, and a Cure Service Dispatcher to recommend suitable cures and thus deliver prompt services and in-time contents to users.

scholarly journals Adherence Barriers and Dulera Adherence in an Asthma Adherence Management Study: Preliminary Results

2016 ◽  
Vol 137 (2) ◽  
pp. AB184
Author(s):  
Andrew G. Weinstein ◽  
Deborah A. Gentile ◽  
Jennifer Maiolo ◽  
Erica Butler ◽  
David P. Skoner
Keyword(s):  
Management Study ◽  
Preliminary Results ◽  
Adherence Management

scholarly journals Adherence management for patients with cancer taking capecitabine: a prospective two-arm cohort study

BMJ Open ◽  
2013 ◽  
Vol 3 (7) ◽  
pp. e003139 ◽  
Author(s):  
Linda Krolop ◽  
Yon-Dschun Ko ◽  
Peter Florian Schwindt ◽  
Claudia Schumacher ◽  
Rolf Fimmers ◽  
...  
Keyword(s):  
Cohort Study ◽  
Patients With Cancer ◽  
Adherence Management

Non-adherence to oral antipsychotics in schizophrenia: Relapse and therapeutic strategies in a 12-month observational study

2011 ◽  
Vol 26 (S2) ◽  
pp. 1362-1362 ◽  
Author(s):  
A. Ciudad ◽  
L. San ◽  
M. Bernardo ◽  
J.M. Olivares ◽  
P. Polavieja ◽  
...  
Keyword(s):  
Lower Risk ◽  
Cox Regression ◽  
Therapeutic Strategies ◽  
Pharmacological Therapy ◽  
Clinical Profiles ◽  
Oral Antipsychotic ◽  
Concomitant Medications ◽  
Time To Relapse ◽  
Adherence Management ◽  
Risk Of Relapse

IntroductionNon-adherence influences schizophrenia prognosis.ObjectivesTo describe the clinical profiles, modifications of the therapeutic strategies and relapse rate of patients with schizophrenia who are at risk of non-adherence to oral antipsychotic (AP) medication.MethodsA cohort of 597 outpatients whose therapy was modified because of risk of non-adherence to oral AP was followed during 12 months. Authors used Cox regression to analyse the time to relapse.ResultsPatients’ mean (SD) age was 40.1 (11.1) and time since diagnosis was 15.2 (10.0) years; 64% were males. The clinical condition was at least moderate in most patients (CGI-S score ≥4 in 87%). Baseline AP medication was modified in 506 (85%) patients and non-pharmacological therapies in 190 (32%). In both cases, the main reason for modifications was insufficient efficacy. Concomitant medications were modified in 15%. The proportion of patients in AP monotherapy decreased in favour of polytherapy, and 15% started depot formulations.During 12 months, 90 patients (15%) relapsed. Among relapsing patients, the proportion on monotherapy decreased to 42%, and the depot prescriptions rose to 28%. The risk of relapse was greater among patients with substance use disorder or familial psychiatric antecedents and lower in patients with poor attitude to AP medication or undergoing modifications of their non-pharmacological therapy at baseline.ConclusionsNon-adherence management was focused on improving efficacy and consisted mainly of modifications of oral AP medication. The recognition and treatment, not necessarily pharmacological, of patients with a poor attitude to medication at baseline might explain their lower risk of relapse.

Sign in / Sign up

Export Citation Format

Share Document